Wang, Feng
Morita, Kiyomi http://orcid.org/0000-0002-0407-1565
DiNardo, Courtney D. http://orcid.org/0000-0001-9003-0390
Furudate, Ken
Tanaka, Tomoyuki
Yan, Yuanqing
Patel, Keyur P.
MacBeth, Kyle J.
Wu, Bin http://orcid.org/0000-0001-9232-4456
Liu, Guowen
Frattini, Mark
Matthews, Jairo A.
Little, Latasha D.
Gumbs, Curtis
Song, Xingzhi
Zhang, Jianhua http://orcid.org/0000-0001-5412-9860
Thompson, Erika J.
Kadia, Tapan M.
Garcia-Manero, Guillermo http://orcid.org/0000-0002-3631-2482
Jabbour, Elias
Ravandi, Farhad
Bhalla, Kapil N. http://orcid.org/0000-0001-5209-5126
Konopleva, Marina http://orcid.org/0000-0002-9347-2212
Kantarjian, Hagop M. http://orcid.org/0000-0002-1908-3307
Andrew Futreal, P. http://orcid.org/0000-0001-8663-2671
Takahashi, Koichi http://orcid.org/0000-0002-8027-9659
Article History
Received: 26 May 2020
Accepted: 1 April 2021
First Online: 10 May 2021
Competing interests
: K.T. receives advisory and consultancy fee from Celgene, Novartis, GSK, Symbio Pharmaceuticals, and Kyowa Hakko Kirin. K.M.B. and M.F. were Celgene employee. B.W. and G.L. were Agios employee. C.D.D. receives research support (to institution) from Abbvie, Agios, Calithera, Cleave, BMS/Celgene, Daiichi-Sankyo, Forma, Loxo, and ImmuneOnc, and is among the Consultant/Advisory Boards at Abbvie, Agios, Celgene/BMS, ImmuneOnc, Novartis, Takeda, and Aprea. C.D.D. is a scientific advisor with stock options from Notable Labs. K.N.B. is a consultant for Iterion Therapeutics. E.J. receives research support (to institution) and consultancy fee from AbbVie, Amgen, Adaptive biotechnologies, Ascentage, BMS/Celgene, Genentech, Pfizer, and Takeda. H.K. receives research grants from AbbVie, Amgen, Ascentage, BMS, Daiichi-Sankyo, Immunogen, Jazz, Novartis, Pfizer and Sanofi, and honoraria from AbbVie, Actinium (Advisory Board), Adaptive Biotechnologies, Amgen, Apptitude Health, BioAscend, Daiichi-Sankyo, Delta Fly, Janssen Global, Novartis, Oxford Biometical, Pfizer and Takeda. F.R. is member of advisory boards for Celgene, BMS, and Agios, and receives honoraria from them. K.P. receives consultancy fee from Novartis. T.K. receives consulting fee from AbbVie, Agios, Daiichi-Sankyo, Genentech, Jazz Pharmaceuticals, Liberum, Novartis, Pfizer, Sanofi-Aventis, and receives research support (to institution) from AbbVie, Amgen, BMS, Genentech, Jazz Pharmaceuticals, Pfizer, Cellenkos, Ascentage, Genfleet, Astellas, and AstraZeneca, and honoraria from Genzyme. All other authors declare no competing interests.